Helmut Plett
Overview
Explore the profile of Helmut Plett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Donato V, Giannini A, Galli V, Di Donna M, Congiu M, Garganese G, et al.
Int J Gynecol Cancer
. 2024 Jul;
34(8):1133-1139.
PMID: 39002981
Objective: To assess if the use of a V-Y reconstructive flap after excisional radical surgery positively influences the surgical outcomes in patients with vulvar cancer. Methods: This was a multicenter,...
2.
Westermann T, Karabeg E, Heitz F, Traut A, Plett H, Moubarak M, et al.
Int J Gynecol Cancer
. 2024 Apr;
34(6):898-905.
PMID: 38627034
Objective: Borderline tumors of the ovary are a rare group of ovarian neoplasms with distinctive histological features. Considering their favorable prognosis and occurrence at a younger age, fertility-sparing surgery may...
3.
Klar M, Plett H, Harter P, Heitz F, Kommoss S, Hartkopf A, et al.
J Surg Oncol
. 2023 Mar;
128(1):111-118.
PMID: 36975108
Background: Malignant sex cord-stromal cell tumours (SCST) account for only 7% of ovarian malignancies. The Arbeitsgemeinschaft fuer Gynaekologische Onkologie (AGO) study group has established a clinicopathological database to provide an...
4.
Plett H, Ricciardi E, Vacaru V, Ramspott J, Colombo N, Sehouli J, et al.
Int J Gynecol Cancer
. 2023 Feb;
33(5):734-740.
PMID: 36759002
Objective: Adult granulosa cell tumors represent less than 5% of all ovarian malignancies. The aim of this study was to analyze the clinicopathological parameters and their impact on progression-free and...
5.
Muallem M, Sehouli J, Miranda A, Plett H, Sayasneh A, Diab Y, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406468
(1) Background: plastic reconstruction in vulvar surgery can lead to a better treatment outcome than primary closure. This study aims to compare the preoperative parameters (co-morbidities and tumor size) and...
6.
Ramspott J, Baert T, MacKintosh M, Traut A, Ataseven B, Bommert M, et al.
Arch Gynecol Obstet
. 2021 Mar;
304(4):1021-1032.
PMID: 33661392
Purpose: The chemotherapy response score (CRS) is a histopathological tool to evaluate response to neoadjuvant chemotherapy (NACT) in high-grade serous ovarian cancer (OC). We critically evaluated the clinical value of...
7.
Gungorduk K, Plett H, Gulseren V, Meydanli M, Boyraz G, Ozdemir I, et al.
Oncol Res Treat
. 2020 Nov;
44(1-2):43-51.
PMID: 33249415
Aim: The clinicopathologic characteristics, recurrence patterns, and survival of patients with grade 3 endometrial cancer (G3-EAC) and uterine carcinosarcoma (UCS) were compared. Materials And Methods: The medical records of patients...
8.
Grabowski J, Glajzer J, Richter R, Plett H, Muallem M, Braicu E, et al.
Int J Gynecol Cancer
. 2020 Oct;
31(1):98-103.
PMID: 33127866
Objective: Low grade serous ovarian cancers characterize a unique clinical pattern and likely less frequent incidence of lymphatic metastasis. The expression level of Ki67 is associated with differences in prognosis...
9.
Plett H, Filippova O, Garbi A, Kommoss S, Rosendahl M, Langstraat C, et al.
Gynecol Oncol
. 2020 Sep;
159(2):434-441.
PMID: 32919778
Background: Standard of care in patients with advanced ovarian cancer (AOC) is upfront surgery followed by chemotherapy. Neoadjuvant chemotherapy (NACT) and interval debulking surgery (IDS) is an alternative in selected...
10.
Ataseven B, Tripon D, Rhiem K, Harter P, Schneider S, Heitz F, et al.
Geburtshilfe Frauenheilkd
. 2020 Sep;
80(9):932-940.
PMID: 32905297
mutations are the leading cause of hereditary epithelial ovarian cancer (EOC). The German Consortium for Hereditary Breast and Ovarian Cancer has defined inclusion criteria, which are retrievable as a checklist...